’’ ’Embattled Canadian drugmaker Valeant Pharmaceuticals may have to restate its earnings results, ’ ’The stock was last trading down more than 10% in the late session at around $68 per share.’ ’’ ’’ ’In October, Andrew Left, founder of  ’ ’’ ’’ ’’ ’Embattled Canadian drugmaker Valeant. ..’